Dr. John Leonard, an esteemed physician-scientist who specializes in lymphoma research and treatment, has been named senior associate dean for innovation and initiatives at Weill Cornell Medicine.
New Approaches to Breast Cancer Treatment
September 2, 2020
A preclinical model of a common type of breast cancer provides new insight into why an immunotherapy known as checkpoint inhibition has not yet been effective against the cancer, according to researchers from Weill Cornell Medicine. Research with the model also suggests new approaches to treatment.
Dr. Lewis Cantley Wins Janssen Award
August 25, 2020
Dr. Lewis Cantley, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, and a Member of the Englander Institute for Precision Medicine, has won the 2020 Dr. Paul Janssen Award for Biomedical Research.
More Effective Therapies for Bladder Cancer
August 24, 2020
Each year, 80,000 people in the United States are newly diagnosed with bladder cancer, and more than 17,000 lose their lives due to the disease. It ranks as the fourth most common type of cancer in men—but for decades, there was a paucity of research and little understanding of its unique biology, leaving clinicians with limited treatment options.
New NIH Grant to Study COVID19
August 7, 2020
Weill Cornell Medicine’s Clinical and Translational Science Center (CTSC) has been awarded a grant from the National Institutes of Health for COVID-19 research. The two-year $1.5 million grant will fund projects led by Dr.
Uncloaking Tumors
August 3, 2020
Localized radiation therapy against a tumor can trigger a beneficial immune response throughout the body by releasing DNA from mitochondria into the cytoplasm of tumor cells. The findings suggest a new strategy for boosting this response, which may significantly increase the effectiveness of radiation against certain cancers.
A Conversation with Pinkal Desai, M.D.
July 28, 2020
We are pleased to introduce our newest EIPM Member Pinkal Desai, M.D.
Dr. Desai is an Assistant Professor of Medicine in the WCM Hematology and Medical Oncology Department and is the Charles, Lillian, and Betty Neuwirth Clinical Scholar in Oncology, and Clinical Director of the EIPM Molecular Aging Institute.
We hope you enjoy learning more about her research interests.
Q: Can you please tell our readers about your work?
EIPM's Q2 2020 External Newsletter
July 1, 2020
July 2020,
Dear Friends of the EIPM,
Thank you for signing up on our website to receive this quarterly newsletter, I'm thrilled to share news about the important advances we're making in research and efforts to bring more effective treatments to patients during these extraordinary times.
'Mini Brain' Models Study Tumors & Treatments
June 23, 2020
A new technique that involves growing brain tumors in a miniature laboratory model of the human brain recreated the complex genetics of the disease better than other approaches, according to research by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The findings suggest that the technique may provide scientists with a more powerful way to develop and test personalized treatments for these tumors, known as glioblastomas.
A Conversation with Dr. Ravi Sharaf
June 3, 2020
We hope you enjoy the following conversation with EIPM Member Dr. Ravi Sharaf.
Ravi Sharaf, M.D., M.S., is a Member of the Englander Institute for Precision Medicine, an Associate Professor of Medicine (Gastroenterology) with a secondary appointment as Associate Professor of Population Health Sciences (Epidemiology).